Sphingolipid metabolic subtyping defines SPHK1 as an oncogene and characterizes immunosuppressive TME features in gastric cancer

Cancer Cell International · Published 2026-07-27 · DOI 10.1186/s12935-026-04401-4

Free full text

Authors (3)

Zeyu Wang, Zhuying Yue, Chengkai Jiang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Wang, Z., Yue, Z., Jiang, C. (2026). Sphingolipid metabolic subtyping defines SPHK1 as an oncogene and characterizes immunosuppressive TME features in gastric cancer. Cancer Cell International. https://doi.org/10.1186/s12935-026-04401-4

Related articles